SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 5 filers reported holding SEATTLE GENETICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $380,000 | +30.1% | 2,239 | +49.9% | 0.44% | +47.8% |
Q3 2020 | $292,000 | -23.2% | 1,494 | -33.3% | 0.30% | +104.9% |
Q2 2020 | $380,000 | +187.9% | 2,239 | +96.4% | 0.14% | -33.0% |
Q1 2020 | $132,000 | -11.4% | 1,140 | -44.3% | 0.22% | +121.6% |
Q3 2019 | $149,000 | – | 2,048 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |